Atlas

FDA-Inspected Site

Luoxin Aurovitas Pharma (Chengdu) Co., Ltd

2 FDA inspections are on record for Luoxin Aurovitas Pharma (Chengdu) Co., Ltd in Chengdu, China.

483· Form 483 issued

Chengdu, China · Last updated August 15, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2026-06-16.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
8 Jun 2026 – 16 Jun 2026Human Drugs483On file
3 Aug 2023 – 11 Aug 2023Human DrugsClean

Investigators

FDA investigators tied to this site in the record.

Bijoy Panicker1 insp.
Ankur C Patel1 insp.
Jose M Cayuela1 insp.

Full site report

Get the verbatim findings behind Luoxin Aurovitas Pharma (Chengdu) Co., Ltd's 1 Form 483

The full inspection record, as Atlas holds it, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat